Remove Chemotherapy Remove Generic Medicine Remove Immunization
article thumbnail

CHMP meeting highlights – January 2025

European Pharmaceutical Review

Biosimilars given a positive opinion Dyrupeg (pegfilgrastim) to reduce the duration of neutropenia and help prevent febrile neutropenia following chemotherapy. Pavblu (aflibercept) and Skojoy (aflibercept) for the treatment of neovascular age-related macular degeneration and visual impairment related to various conditions.